CERIBELLI, Angela
 Distribuzione geografica
Continente #
EU - Europa 4.558
NA - Nord America 2.352
AS - Asia 1.081
SA - Sud America 169
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 8.179
Nazione #
IT - Italia 3.459
US - Stati Uniti d'America 2.299
CN - Cina 408
SG - Singapore 348
UA - Ucraina 226
DE - Germania 225
BR - Brasile 147
FR - Francia 119
GB - Regno Unito 108
IE - Irlanda 101
HK - Hong Kong 98
VN - Vietnam 78
FI - Finlandia 68
RU - Federazione Russa 65
TR - Turchia 43
IN - India 38
NL - Olanda 33
ES - Italia 29
CA - Canada 27
EE - Estonia 22
RO - Romania 19
SE - Svezia 16
BD - Bangladesh 15
MX - Messico 14
PL - Polonia 14
AR - Argentina 12
BE - Belgio 12
JP - Giappone 10
CH - Svizzera 9
AT - Austria 8
PK - Pakistan 6
IQ - Iraq 5
PA - Panama 5
ZA - Sudafrica 5
EC - Ecuador 4
ID - Indonesia 4
LT - Lituania 4
LU - Lussemburgo 4
AE - Emirati Arabi Uniti 3
EU - Europa 3
IR - Iran 3
JO - Giordania 3
KZ - Kazakistan 3
LI - Liechtenstein 3
MA - Marocco 3
UZ - Uzbekistan 3
CL - Cile 2
CY - Cipro 2
DK - Danimarca 2
DZ - Algeria 2
IL - Israele 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BW - Botswana 1
CM - Camerun 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
GT - Guatemala 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MS - Montserrat 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
PE - Perù 1
PY - Paraguay 1
SA - Arabia Saudita 1
SV - El Salvador 1
UY - Uruguay 1
VE - Venezuela 1
Totale 8.179
Città #
Milan 246
Fairfield 240
Woodbridge 194
Rome 187
Jacksonville 171
Ashburn 161
Singapore 158
Beijing 143
Houston 125
Cambridge 107
Florence 104
Hong Kong 97
Seattle 91
Ann Arbor 89
Wilmington 87
Chandler 74
Princeton 74
New York 72
Los Angeles 60
Nanjing 59
Turin 54
Trieste 53
Bologna 45
Dublin 39
The Dalles 38
Helsinki 37
Verona 37
Udine 35
Istanbul 34
Genoa 33
Ho Chi Minh City 32
Padova 32
Dallas 31
Brescia 30
Munich 26
Des Moines 25
Moscow 24
Pisa 24
Genova 23
Tallinn 22
Modena 21
Syracuse 21
Lancaster 20
Menlo Park 20
Reggio Nell'emilia 20
Nanchang 19
San Diego 19
London 16
Mumbai 16
Torino 16
Trento 16
Bari 15
Naples 15
Shenyang 15
Buffalo 14
Catania 13
Desio 13
Hebei 13
Sassari 13
Tianjin 13
Venice 13
Bergamo 12
Brooklyn 12
Brussels 12
Chicago 12
Dearborn 12
San Francisco 12
Changsha 11
Hanoi 11
Jiaxing 11
Palermo 11
Redwood City 11
Shanghai 11
Pozzuolo Del Friuli 10
Redondo Beach 10
Tokyo 10
Manchester 9
Perugia 9
Turriaco 9
Cagliari 8
Cosenza 8
Fiumicino 8
Francenigo 8
Frankfurt am Main 8
Montreal 8
Napoli 8
Stockholm 8
São Paulo 8
Hangzhou 7
Kunming 7
Lecco 7
Manresa 7
Phoenix 7
Toronto 7
Vicenza 7
Arezzo 6
Bucharest 6
Caserta 6
Cernobbio 6
Cervignano del Friuli 6
Totale 3.900
Nome #
ANTICORPI ANTI-TH/TO NELLA SCLEROSI SISTEMICA (SSC): CORRELAZIONI CLINICHE E IMMUNOLOGICHE 2.338
ANTICORPI ANTI-RNA POLIMERASI III: UN MARKER DI ESORDIO PRECOCE DI SCLEROSI SISTEMICA 1.764
Anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus patients with articular involvement: a predictive marker for erosive disease? 200
Anti-RNA polymerase III antibodies as a risk marker for early Gastric Antral Vascular Ectasia (GAVE) in systemic sclerosis 194
Anti-RNA polymerase III antibodies: A marker of systemic sclerosis with rapid onset and skin thickening progression 186
Anti-argonaute2 (Ago2/Su) and -Ro antibodies identified by immunoprecipitation in primary anti-phospholipid syndrome (PAPS). 169
Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies 164
Anti-cardiolipin and anti-beta2-glycoprotein I antibodies: performance of new commercial ELISA kits. 162
Anti-MJ/NXP-2 autoantibody specificity in a cohort of adult Italian patients with polymyositis/dermatomyositis. 156
Anti-Th/To are common antinucleolar autoantibodies in Italian patients with scleroderma. 155
Autoimmune polyendocrine Syndromes 149
Aortic stiffness and left ventricular hypertrophy in rheumatoid arthritis: Comment on the article by Rudominer et al. 138
Myositis-specific autoantibodies and their association with malignancy in Italian patients with polymyositis and dermatomyositis 130
Autoantibodies to survival of motor neuron complex in patients with polymyositis: Immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins 127
IL COMPLEMENTO NELLA GRAVIDANZA DI DONNE AFFETTE DA SINDROME DA ANTICORPI ANTIFOSFOLIPIDI PRIMARIA 123
Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis 114
International cohort study of 73 anti-Ku-positive patients: Association of p70/p80 anti-Ku antibodies with joint/bone features and differentiation of disease populations by using principal-components analysis 112
Evaluation of a novel particle-based assay for detection of autoantibodies in idiopathic inflammatory myopathies. 110
LUPUS ERITEMATOSO SISTEMICO AD ESORDIO TARDIVO: CARATTERISTICHE CLINICHE ED IMMUNOLOGICHE 108
Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. 106
ANTI-RNA POLYMERASE III ANTIBODIES AS A RISK MARKER FOR EARLY DEVELOPMENT OF GASTRIC ANTRAL VASCULAR ECTASIA IN SYSTEMIC SCLEROSIS 104
AUMENTO DELLA PROTEINA C-REATTIVA, ANTICORPI ANTI-CCP E FATTORE REUMATOIDE NELL'ARTRITE LUPICA 104
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects] 104
Complement cascade in systemic lupus erythematosus: Analyses of the three activation pathways 102
Comparison of early and late onset systemic lupus erythematosus 97
ANTICORPI ANTI-SU NELLA SINDROME DA ANTICORPI ANTI-FOSFOLIPIDI PRIMARIA (PAPS) 89
FIRST REPORT OF ANTI-MDA5 ANTIBODIES IN A COHORT OF ITALIAN PATIENTS WITH DERMATOMYOSITIS: CLINICAL AND SEROLOGIC CORRELATIONS 86
The clinical phenotype of Systemic Sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort 81
DETECTION OF ANTI-ARGONAUTE2 (AGO2/SU) AND -RO ANTIBODIES BY IMMUNOPRECIPITATION, IN PRIMARY ANTI-PHOSPHOLIPID SYNDROME (PAPS) PATIENTS: ARE THEY PREDICTIVE FOR EVOLUTION IN SYSTEMIC LUPUS ERYTHEMATOSUS? 74
Left ventricular sistolic and diastolic function in rheumatoid arthritis. 71
Studio ecocardiografico in pazienti affetti da artrite reumatoide. 70
LEFT VENTRICULAR FUNCTION IN RHEUMATOID ARTHRITIS DURING ANTI-TNF ALPHA TREATMENT: PROSPECTIVE STUDY 69
Left ventricular Systolic and diastolic function in rheumatoid arthritis 68
STUDIO ECOCARDIOGRAFICO IN PAZIENTI AFFETTI DA ARTRITE REUMATOIDE 67
Hepatitis C virus infection and primary Sjögren's Syndrome: A clinical and serologic description of 9 patients 66
An Italian Multicenter Study on Anti-NXP2 Antibodies: Clinical and Serological Associations 65
Comparison of Lineblot and Immunoprecipitation Methods in the Detection of Myositis-Specific and Myositis-Associated Antibodies in Patients with Idiopathic Inflammatory Myopathies: Consistency with Clinical Diagnoses 63
Systemic Sclerosis-Specific Antibodies: Novel and Classical Biomarkers 58
Cell damage shifts the microRNA content of small extracellular vesicles into a Toll-like receptor 7-activating cargo capable to propagate inflammation and immunity 55
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study-Joint and Skin (BeRLiSS-JS) 52
Totale 8.250
Categoria #
all - tutte 25.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.306


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021603 0 0 0 0 0 94 71 100 106 77 109 46
2021/20221.052 53 137 66 43 99 90 124 70 83 91 86 110
2022/2023729 78 20 32 27 49 113 27 68 149 38 67 61
2023/2024621 29 32 51 36 34 97 56 30 98 35 48 75
2024/20251.146 56 48 39 142 131 113 85 79 93 77 172 111
2025/20261.043 160 227 112 256 191 97 0 0 0 0 0 0
Totale 8.250